Robert E. Mosser

Array ( [id] => 5777403 [patent_doc_number] => 20060106043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Method for treating HIV infection through co-administration of tipranavir and etravirine' [patent_app_type] => utility [patent_app_number] => 11/248805 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1346 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106043.pdf [firstpage_image] =>[orig_patent_app_number] => 11248805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4652244 [patent_doc_number] => 20080039500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Cerebral Infarction Suppressant' [patent_app_type] => utility [patent_app_number] => 11/665468 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5443 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039500.pdf [firstpage_image] =>[orig_patent_app_number] => 11665468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807223 [patent_doc_number] => 20060093577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Combination anti-viral compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 11/244811 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12396 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20060093577.pdf [firstpage_image] =>[orig_patent_app_number] => 11244811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859065 [patent_doc_number] => 20080267915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Hcv Ns3-Ns4a Protease Inhibition' [patent_app_type] => utility [patent_app_number] => 11/576017 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12069 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267915.pdf [firstpage_image] =>[orig_patent_app_number] => 11576017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127392 [patent_doc_number] => 08575342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'HIV inhibiting 5-heterocyclyl pyrimidines' [patent_app_type] => utility [patent_app_number] => 11/575818 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19584 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11575818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5881539 [patent_doc_number] => 20060030622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Compounds and methods for the treatment of urogenital disorders' [patent_app_type] => utility [patent_app_number] => 11/236096 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17002 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030622.pdf [firstpage_image] =>[orig_patent_app_number] => 11236096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398364 [patent_doc_number] => 20090318427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'BENZODIAZEPINE DERIVATIVES FOR TREATING HEPATITIS C INFECTION' [patent_app_type] => utility [patent_app_number] => 12/067318 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13140 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318427.pdf [firstpage_image] =>[orig_patent_app_number] => 12067318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5727526 [patent_doc_number] => 20060058286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Methods of treating HIV infection' [patent_app_type] => utility [patent_app_number] => 11/227526 [patent_app_country] => US [patent_app_date] => 2005-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7147 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058286.pdf [firstpage_image] =>[orig_patent_app_number] => 11227526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691445 [patent_doc_number] => 20070232588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Anti-parasitic and/or anti-viral and/or anti-microbial compositions' [patent_app_type] => utility [patent_app_number] => 11/224981 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4193 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232588.pdf [firstpage_image] =>[orig_patent_app_number] => 11224981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887526 [patent_doc_number] => 20060275260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Use of imatinib to treat liver disorders and viral infections' [patent_app_type] => utility [patent_app_number] => 11/228982 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5321 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275260.pdf [firstpage_image] =>[orig_patent_app_number] => 11228982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658172 [patent_doc_number] => 20080027034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/661150 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5767 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027034.pdf [firstpage_image] =>[orig_patent_app_number] => 11661150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977773 [patent_doc_number] => 08071633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Pharmaceutical composition for treating spinocerebellar ataxia ' [patent_app_type] => utility [patent_app_number] => 11/662182 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5373 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071633.pdf [firstpage_image] =>[orig_patent_app_number] => 11662182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5715404 [patent_doc_number] => 20060078767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Odorant, liquid fuel for fuel cell and fuel cell' [patent_app_type] => utility [patent_app_number] => 11/220502 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4300 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078767.pdf [firstpage_image] =>[orig_patent_app_number] => 11220502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638189 [patent_doc_number] => 20060069163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Method for treating Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 11/220232 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5594 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069163.pdf [firstpage_image] =>[orig_patent_app_number] => 11220232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978607 [patent_doc_number] => 20050288325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Therapy for andropause using estrogen agonists/antagonists and testosterone' [patent_app_type] => utility [patent_app_number] => 11/219267 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13699 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288325.pdf [firstpage_image] =>[orig_patent_app_number] => 11219267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 609650 [patent_doc_number] => 07151117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-19 [patent_title] => 'Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions' [patent_app_type] => utility [patent_app_number] => 11/217578 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 6639 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/151/07151117.pdf [firstpage_image] =>[orig_patent_app_number] => 11217578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10888229 [patent_doc_number] => 08912225 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'VEGF inhibition' [patent_app_type] => utility [patent_app_number] => 11/661460 [patent_app_country] => US [patent_app_date] => 2005-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8997 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11661460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5711069 [patent_doc_number] => 20060052414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Compositions and methods for treating or preventing Hepadnaviridae infection' [patent_app_type] => utility [patent_app_number] => 11/202867 [patent_app_country] => US [patent_app_date] => 2005-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12263 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052414.pdf [firstpage_image] =>[orig_patent_app_number] => 11202867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051915 [patent_doc_number] => 20070032460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Use of voacamine and related compounds in the treatment of malaria' [patent_app_type] => utility [patent_app_number] => 11/196765 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3189 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032460.pdf [firstpage_image] =>[orig_patent_app_number] => 11196765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168566 [patent_doc_number] => 07666891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Heterocyclic antiviral compounds' [patent_app_type] => utility [patent_app_number] => 11/190478 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18164 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666891.pdf [firstpage_image] =>[orig_patent_app_number] => 11190478 [rel_patent_id] =>[rel_patent_doc_number] =>)